{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T22:58:13Z","timestamp":1793228293277,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1016\/j.clinthera.2008.11.019","type":"journal-article","created":{"date-parts":[[2008,12,25]],"date-time":"2008-12-25T10:20:57Z","timestamp":1230200457000},"page":"2133-2145","source":"Crossref","is-referenced-by-count":101,"title":["The economics of pediatric formulation development for off-patent drugs"],"prefix":"10.1016","volume":"30","author":[{"given":"Christopher-Paul","family":"Milne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon B.","family":"Bruss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2008.11.019_bib1","series-title":"New Drug Development: A Regulatory Overview","first-page":"339","article-title":"The pediatric studies initiative","author":"Milne","year":"2005"},{"key":"10.1016\/j.clinthera.2008.11.019_bib2","unstructured":"Tobias LD, Harkness J. IAPO Briefing Paper on Paediatric Medicines and Clinical Research (November 2006). International Alliance of Patients' Organizations (IAPO) (quoting MedChild Institute). Located at: Louis Lasagna Library, Tufts Center for the Study of Drug Development, Boston, Massachusetts."},{"key":"10.1016\/j.clinthera.2008.11.019_bib3","unstructured":"Peds Subcommittee Hears Oncology Update (summary of minutes of US FDA Pediatric Oncology Subcommittee meeting). DIA Dispatch, October 21, 2005. Located at: Louis Lasagna Library, Tufts Center for the Study of Drug Development, Boston, Massachusetts."},{"key":"10.1016\/j.clinthera.2008.11.019_bib4","first-page":"6","article-title":"Pediatric formula best effort presumption is built into exclusivity-Botstein","volume":"61","year":"1999","journal-title":"The Pink Sheet"},{"key":"10.1016\/j.clinthera.2008.11.019_bib5_1","unstructured":"Pediatric Drug Development. Last updated August 28, 2008."},{"key":"10.1016\/j.clinthera.2008.11.019_bib6_1","unstructured":"US Food and Drug Administration. Pediatric exclusivity labeling changes as of August 8, 2007."},{"key":"10.1016\/j.clinthera.2008.11.019_bib7","first-page":"9","article-title":"Special dispensations can be made to pay","author":"Law","year":"2004","journal-title":"Scrip Magazine"},{"key":"10.1016\/j.clinthera.2008.11.019_bib8_1","unstructured":"Child medicine additive concern. BBC News, March 10, 2007."},{"key":"10.1016\/j.clinthera.2008.11.019_bib9_1","unstructured":"US Dept of Health and Human Services, Food and Drug Administration. Regulations Requiring Manufacturers to Assess the Safety and Effectiveness of New Drugs and Biological Products in Pediatric Patients; Final Rule [see Comment 39]. Federal Register. December 2, 1998 (volume 63, number 231; pages 66631-66672)."},{"key":"10.1016\/j.clinthera.2008.11.019_bib10_1","unstructured":"Committee for Medicinal Products for Human Use (CHMP). Reflection Paper: Formulations of choice for the paediatric population. (EMEA\/CHMP\/PEG\/194810\/2005)."},{"key":"10.1016\/j.clinthera.2008.11.019_bib11","series-title":"The Pediatric Studies Incentive: Equal Medicines for All","author":"Milne","year":"2001"},{"key":"10.1016\/j.clinthera.2008.11.019_bib12_1","unstructured":"National Institute of Child Health and Human Development. Updated August 17, 2006."},{"key":"10.1016\/j.clinthera.2008.11.019_bib13","series-title":"Pediatric Study Costs Increased 8-Fold Since 2000 as Complexity Level Grew","year":"2007"},{"key":"10.1016\/j.clinthera.2008.11.019_bib14","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1001\/jama.297.5.480","article-title":"Economic return of clinical trials performed under the pediatric exclusivity program","volume":"297","author":"Li","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2008.11.019_bib15","first-page":"491","article-title":"Exploring the frontiers of law and science: FDAMA's pediatric studies incentive","volume":"57","author":"Milne","year":"2002","journal-title":"Food & Drug Law J"},{"key":"10.1016\/j.clinthera.2008.11.019_bib16","first-page":"22","article-title":"Studies for kids, drugs for seniors","volume":"6","author":"Wechsler","year":"1997","journal-title":"Appl Clin Trials"},{"key":"10.1016\/j.clinthera.2008.11.019_bib17_1","unstructured":"US Dept of Health and Human Services, Food and Drug Administration. Guidance for industry: How to comply with the Pediatric Research Equity Act."},{"key":"10.1016\/j.clinthera.2008.11.019_bib18_1","unstructured":"European Medicines Agency (EMEA). ICH Topic E 11: Clinical Investigation of Medicinal Products in the Paediatric Population. Note for guidance on clinical investigation of medicinal products in the paediatric population (CPMP\/ICH\/2711\/99)."},{"key":"10.1016\/j.clinthera.2008.11.019_bib19_1","first-page":"1","article-title":"Safety, economics converge","volume":"25","author":"Ladley","year":"2006","journal-title":"Med Ad News"},{"key":"10.1016\/j.clinthera.2008.11.019_bib19_2","first-page":"50","volume":"25","year":"2006","journal-title":"Med Ad News"},{"key":"10.1016\/j.clinthera.2008.11.019_bib20","unstructured":"Durrant C. Pediatric Market: United States. Presentation at Pharmaceutical Education Associates conference on Pediatric Drug Development, Washington, DC, Febuary 23-24, 2004. Located at: Louis Lasagna Library, Tufts Center for the Study of Drug Development, Boston, Massachusetts."},{"key":"10.1016\/j.clinthera.2008.11.019_bib21_1","first-page":"28","article-title":"Drug and Formulary Trends","volume":"38","year":"2003"},{"key":"10.1016\/j.clinthera.2008.11.019_bib21_2","series-title":"Source: 2002 Medco Health Drug Trend Report","first-page":"28","year":"2002"},{"key":"10.1016\/j.clinthera.2008.11.019_bib22","first-page":"16","article-title":"Global pediatric drug sales to top $46B","volume":"33","year":"2006","journal-title":"Pharma Marketletter"},{"key":"10.1016\/j.clinthera.2008.11.019_bib23","first-page":"42","article-title":"The trials of youth: Bringing children into clinical research","volume":"9","author":"Myshko","year":"2003","journal-title":"Pharmavoice"},{"key":"10.1016\/j.clinthera.2008.11.019_bib24","first-page":"27","article-title":"World vaccine market to exceed $15 billion in 2012","volume":"34","year":"2007","journal-title":"Pharma Marketletter"},{"key":"10.1016\/j.clinthera.2008.11.019_bib25","first-page":"24","article-title":"Shifting the pediatric paradigm","volume":"3","author":"Konopka","year":"2006","journal-title":"PharmaVoice"},{"key":"10.1016\/j.clinthera.2008.11.019_bib26_1","unstructured":"Federal Interagency Forum on Child and Family Statistics. America's Children: Key National Indicators of Well-Being, 2005: page vii. Washington, DC: US Government Printing Office."},{"key":"10.1016\/j.clinthera.2008.11.019_bib27","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1377\/hlthaff.23.2.168","article-title":"The impact of the \u2018aging of America\u2019 on children","volume":"23","author":"Freed","year":"2004","journal-title":"Health Aff"},{"key":"10.1016\/j.clinthera.2008.11.019_bib28_1","unstructured":"Population Reference Bureau. 2006 world population data sheet."},{"key":"10.1016\/j.clinthera.2008.11.019_bib29","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1056\/NEJMp048313","article-title":"Saving the children-improving childhood cancer treatment in developing countries","volume":"352","author":"Ribeiro","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2008.11.019_bib30","unstructured":"WHO 2000: Population by age and sex, 1995 and 2025. Located at: Louis Lasagna Library, Tufts Center for the Study of Drug Development, Boston, Massachusetts."},{"key":"10.1016\/j.clinthera.2008.11.019_bib31_1","unstructured":"Mundell EJ. Rise in child chronic illness could swamp health care. August 2007."},{"key":"10.1016\/j.clinthera.2008.11.019_bib32_1","unstructured":"Agency for Healthcare Research and Quality (AHRQ). Fact Sheet: Selected Findings on Child and Adolescent Health Care from the 2004 National Healthcare Quality\/Disparities Reports. AHRQ Publication 05-PO11."},{"key":"10.1016\/j.clinthera.2008.11.019_bib33_1","unstructured":"Agency for Healthcare Research and Quality (AHRQ). Child Health Research Findings; Jan 2001-Dec 2004. [Click on Chronic Illnesses in table of contents]."},{"key":"10.1016\/j.clinthera.2008.11.019_bib34","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1001\/jama.296.14.1780","article-title":"Theme issue on chronic diseases in infants, children, and young adults: Call for papers","volume":"296","author":"DeAngelis","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2008.11.019_bib35","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1377\/hlthaff.23.5.9","article-title":"The transformation of child health in the United States","volume":"23","author":"Wise","year":"2004","journal-title":"Health Aff (Millwood)"},{"key":"10.1016\/j.clinthera.2008.11.019_bib36","unstructured":"Summary Health Statistics for US Children: National Health Interview Survey, 1998. Series 10, Number 208. Hyattsville, Md: DHHS, CDC, National Center for Health Statistics; October 2002. DHHS Publication (PHS) 2002-1536."},{"key":"10.1016\/j.clinthera.2008.11.019_bib37","unstructured":"Summary Health Statistics for US Children: National Health Interview Survey, 2005. Series 10, Number 231. Hyattsville, Md: DHHS, CDC, National Center for Health Statistics; December 2006. DHHS Publication (PHS) 2007-1559."},{"key":"10.1016\/j.clinthera.2008.11.019_bib38","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1177\/009286150003400129","article-title":"The health of the world's children: What goes around, comes around","volume":"34","author":"Milne","year":"2000","journal-title":"Drug Info J"},{"key":"10.1016\/j.clinthera.2008.11.019_bib39_1","unstructured":"WHO. Facts and Figures from the World Health Report 2005."},{"key":"10.1016\/j.clinthera.2008.11.019_bib40","first-page":"18","article-title":"FlashDose product","volume":"2712","author":"Biovail files for NDA for zolpidem","year":"2002","journal-title":"Scrip Magazine"},{"key":"10.1016\/j.clinthera.2008.11.019_bib41","article-title":"MSF calls on pharma cos to make child-friendly versions of anti-AIDS medicines","year":"2005","journal-title":"Forbes"},{"key":"10.1016\/j.clinthera.2008.11.019_bib42","article-title":"French publish list of paediatric medicine needs","year":"2004","journal-title":"Scrip Magazine"},{"key":"10.1016\/j.clinthera.2008.11.019_bib43","article-title":"WHO and UNICEF push to improve children's access to essential medicines","year":"2006","journal-title":"Scrip Magazine"},{"key":"10.1016\/j.clinthera.2008.11.019_bib44","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1542\/peds.104.S3.585","article-title":"An update on the therapeutic orphan","volume":"104","author":"Wilson","year":"1999","journal-title":"Pediatrics"},{"key":"10.1016\/j.clinthera.2008.11.019_bib45","unstructured":"Better pharmaceuticals for children: Assessment and opportunities. Hearing of the Committee on Health, Education, Labor, and Pensions. United States Senate. May 8, 2001. (Quoting testimony of Stephen P. Spielberg, MD, PhD, then vicepresident of pediatric drug development for Janssen Pharmaceuticals). Washington, DC: US Government Printing Office; 2001. Located at: Louis Lasagna Library, Tufts Center for the Study of Drug Development, Boston, Massachusetts."}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014929180800413X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014929180800413X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T05:31:26Z","timestamp":1684819886000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014929180800413X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":47,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["S014929180800413X"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2008.11.019","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11]]}}}